CABG reduces cardiovascular mortality in ischemic heart failure regardless of age

There should be no age cutoff in offering coronary artery bypass surgery (CABG) to older patients with ischemic heart failure, according to a secondary analysis from the landmark STICH trial. In fact, CABG provided an absolute 14.4% reduction in cardiovascular mortality, compared with medical management, in both the youngest and oldest quartiles of patients with heart failure due to ischemic cardiomyopathy. However, cardiovascular mortality was a secondary endpoint in STICH. Read about the primary endpoint, and the impact CABG has on it, by going to Cardiology News : http://www.ecardiologynews.com/specialty-focus/heart-failure/single-article-page/cabg-reduces-cardiovascular-mortality-in-ischemic-heart-failure-regardless-of-age/ff069be54ebbefc62c43bcc9afdbd907.html.